Recent studies conducted by the FDA now requires all manufacturers to warn patients of possible risk of heart attack and stroke, and to properly label approved usage 2015-03-03 The Food and Drug Agency (FDA) has
The Legal Intelligencer 2014-01-15 Individual suit filings related to the antipsychotic drug Risperdal have been increasing in the Philadelphia Court of Common Pleas, First Judicial District leaders say. The uptick has been steady
2014-09-30 Stephen Sheller presented the feature CLE “American ‘Hustle’: Whistleblowers and Prosecuting False Claims Act Cases” at the Montgomery County Bench Bar conference September 2014. Joined by former Assistant U.S. Attorney Joseph Trautwein,
The Toronto Star 2014-06-26 By: David Bruser News Reporter, Jesse McLean Investigative News reporter, Andrew Bailey Data Analyst, Published on Thu Jun 26 2014 A 15-year-old girl who wanted to clear her acne was prescribed the antibiotic minocycline. The teen
Digital Journal 2014-04-16 The whistleblower attorney team of Sheller P.C. announced today that Astellas Pharma U.S., Inc. has agreed to pay $7.3 million to resolve allegations by the Sheller whistleblower client that Astellas violated the False
Law.com 2014-03-04 Several products liability attorneys say that the recent appearance of lawsuits nationwide against the manufacturers of testosterone therapy drugs indicates the potential for multidistrict litigation and possibly a new mass tort.
DrexelNOW 2014-02-21 Drexel University will begin a major expansion of its nurse-managed health center which is nationally recognized as a model of integrated care. With a new gift of $2.5 million from the